The Centre for Commercialization of Regenerative Medicine (CCRM) has added 13 new companies to its industry consortium as associate members, bringing the company total to nearly 40. The consortium is a key element of CCRM — a Quebec-based network funded by the Centres of Excellence for Commercialization and Research — and its objective of building a strong network for developing collaborative academic-industry projects and a vibrant regenerative medicine industry in Canada. The new consortium members are: Blood Centers of America; Compass Biomedical; ATCC; BioLife Solutions; Cell Scale; Life Technologies; Medinet; Miltenyi; Nikon; Primorigen Biosciences; PCT; Sistemic and Steminent….